ArticleBreast cancer research : BCR2025

CRISPR screens with trastuzumab emtansine in HER2-positive breast cancer cell lines reveal new insights into drug resistance.

Barbara A Lipert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.